Merc
Mar 19, 2021
Navigating Through the Treatment Market Landscape of Head and Neck Cancers
Head and neck cancer account for about 4% of all cancers in the United States. According to GloboCan, the HNSCC incidence in the US in 2020 was estimated to be 63,520 cases. As per estimates, it was observed that HNSCC is slightly more common in men than in women. The research and development and advent of advanced...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
